Skip to main content

Table 3 Comparison of publicly available mutated keratin 14 and keratin 10 sequence data of various skin disease patients with mutated sequence obtained in our study (psoriasis) from Clinvar NCBI database

From: Mutational analysis of epidermal and hyperproliferative type I keratins in mild and moderate psoriasis vulgaris patients: a possible role in the pathogenesis of psoriasis along with disease severity

S. no.

Name

Gene(s)

Condition(s)

Clinical significance (Last reviewed)

GRCh37

GRCh38

Variation ID

Allele ID(s)

Chromosome

Location

Chromosome

Location

1

NM_000526.4(KRT14):c.1264G > A (p.Glu422Lys)

KRT14

EBH-DM

Pathogenic (Apr 1, 2000)

17

39739497

17

41583245

14623

29662

2

NM_000526.4(KRT14):c.1256T > A (p.Leu419Gln)

KRT14

EBH-DM

Pathogenic (Apr 1, 2000)

17

39739505

17

41583253

14622

29661

3

NM_000526.4(KRT14):c.1243T > C (p.Tyr415His)

KRT14

EBH-DM

Pathogenic (Mar 27, 2015)

17

39739518

17

41583266

14621

29660

4

NM_000526.4(KRT14):c.1237G > A (p.Ala413Thr)

KRT 14

Not provided

Pathogenic (Jul 31, 2012)

17

39739524

17

41583272

66319

77216

5

NM_000526.4(KRT14):c.1234A > T (p.Ile412Phe)

KRT14

Not provided

Pathogenic (Apr 2, 2018)

17

39739527

17

41583275

66317

77214

6

NM_000526.4(KRT14):c.1228C > T (p.Gln410Ter)

KRT14

Not provided

Pathogenic (Sep 15, 2016)

17

39739533

17

41583281

66313

77210

7

NM_000526.4(KRT14):c.1162C > T (p.Arg388Cys)

KRT14

Not provided

Pathogenic (Oct 13, 2017)

17

39739599

17

41583347

66306

77203

8

NM_000526.4(KRT14):c.1151T > C (p.Leu384Pro)

KRT14

EBS, Koebner type

Pathogenic (Nov 22, 1991)

17

39739610

17

41583358

14611

29650

9

NM_000526.4(KRT14):c.442C > T (p.Arg148Cys)

KRT14

EBS, Koebner type

Pathogenic (Apr 2, 2018)

17

39742645

17

41586393

66368

77265

10

NM_000526.4(KRT14):c.374G > A (p.Arg125His)

KRT14

EBH-DM

Pathogenic (Oct 30, 2017)

17

39742713

17

41586461

14613

29652

11

NM_000526.4(KRT14):c.357G > A (p.Met119Ile)

KRT14

EBS, autosomal recessive

Pathogenic (Sep 1, 1997)

17

39742730

17

41586478

14620

29659

12

NM_000421.3(KRT10):c.1374-2A > C

KRT10

Not provided

Pathogenic (Nov 25, 2015)

17

38975415

17

40819163

449615

445767

13

NM_000421.3(KRT10):c.1374-2A > G

KRT10

EI, congenital reticular

Pathogenic (Oct 1, 2010)

17

38975415

17

40819163

14581

29620

14

NM_000421.3(KRT10):c.1373 + 2T > C

KRT10

Not provided

Pathogenic (May 9, 2017)

17

38975767

17

40819515

432261

426219

15

NM_000421.3(KRT10):c.1373 + 1G > A

KRT10

EI, congenital reticular

Pathogenic (Oct 1, 2010)

17

38975768

17

40819516

14582

29621

16

NM_000421.3(KRT10):c.1325T > A (p.Leu442Gln)

KRT10

BIE

Pathogenic (Feb 1, 1994)

17

38975817

17

40819565

14575

29614

17

NM_000421.3(KRT10):c.1300C > T (p.Gln434Ter)

KRT10

BIE

Pathogenic (Apr 1, 2006)

17

38975842

17

40819590

29764

38719

18

NM_000421.3(KRT10):c.1281C > A (p.Cys427Ter)

KRT10

BIE

Pathogenic (Jul 1, 2008)

17

38975861

17

40819609

29765

38720

19

NM_000421.3(KRT10):c.494G > C (p.Arg165Pro)

KRT10

Not provided

Likely pathogenic (Sep 1, 2016)

17

38978344

17

40822092

432167

426220

20

NM_000421.3(KRT10):c.482T > C (p.Leu161Ser)

KRT10

BIE

Pathogenic (Aug 21, 1992)

17

38978356

17

40822104

14569

29608

21

NM_000421.3(KRT10):c.479A > C (p.Tyr160Ser)

KRT10

Not provided

Pathogenic (Apr 2, 2018)

17

38978359

17

40822107

66178

77075

22

NM_000421.3(KRT10):c.478T > G (p.Tyr160Asp)

KRT10

BIE

Pathogenic (Feb 1, 1994)

17

38978360

17

40822108

14572

29611

23

NM_000421.3(KRT10):c.467G > A (p.Arg156His)

KRT10

BIE

Pathogenic (Sep 20, 2017)

17

38978371

17

40822119

14573

29612

24

NM_000421.3(KRT10):c.460A > C (p.Asn154His)

KRT10

BIE

Pathogenic (Feb 1, 1994)

17

38978378

17

40822126

14571

29610

  1. EBH-DM epidermolysis bullosa herpetiformis-Dowling Meara, EBS epidermolysis bullosa simplex, EI erythroderma ichthyosiform, BIE Bullous ichthyosiform erythroderma
  2. Italicized words indicate comparison of identical mutation obtained in our study (psoriasis) with other skin disease